Show summary Hide summary
Lorna Shore, the New Jersey deathcore powerhouse, has announced their biggest Australian headline tour to date alongside brand-new New Zealand dates, marking the first time the band will perform across the Tasman. The seven-date run kicks off on October 16, 2026 at John Cain Arena in Melbourne and runs through late October, solidifying the band’s status as one of extreme metal’s most formidable live draws in the Pacific region.
🔥 Quick Facts
- Tour launches October 16, 2026 at John Cain Arena, Melbourne
- Seven total dates across Australia and New Zealand
- Whitechapel joins as special guest on Australian dates only
- The Acacia Strain and Organectomy support the full tour
- New Zealand venues: Wellington (October 26) and Auckland (October 28)
Lorna Shore’s Meteoric Rise in the Deathcore Scene
Lorna Shore has spent the last five years building one of heavy music’s most devoted fanbases globally. The band’s 2021 album “Immortal” marked a turning point in their career, delivering the raw intensity and technical precision that resonated with both longtime deathcore listeners and newcomers alike. By 2024, Lorna Shore had become a consistent festival headliner across major European and North American events, appearing at Sonic Temple, Welcome to Rockville, and other major events in 2026.
This Australian and New Zealand tour upgrade—from touring in support roles to complete arena headline status—reflects the band’s explosive growth in the Pacific market. The John Cain Arena capacity signals the band’s confidence in ticket sales, with the venue typically hosting between 8,000 to 10,000 for rock and metal events. This represents a substantial step up from their previous Australian touring profile.
Lorna Shore announces first New Zealand tour dates plus biggest Australian headline shows
Tom Bergeron and Bobby Bones end feud as Bones wants DWTS trophy back
Tour Dates, Lineups, and Strategic City Selection
The band’s selection of cities demonstrates deliberate market strategy. Melbourne opens the tour as the largest metropolitan area in Australia, while Sydney—the country’s most populous city—has been strategically positioned as the tour’s anchor point. Brisbane, Perth, and Adelaide complete the Australian leg, covering the nation’s major music hubs. The New Zealand dates in Wellington and Auckland represent entirely new territory for the band, expanding their international footprint.
| City | Venue | Date |
| Melbourne | John Cain Arena | October 16, 2026 |
| Adelaide | Unique Venues | October 17, 2026 |
| Perth | Meridian Ballroom | October 19, 2026 |
| Sydney | Hordern Pavilion | October 22, 2026 |
| Brisbane | The Tivoli | October 24, 2026 |
| Wellington | Shed 6 | October 26, 2026 |
| Auckland | The Powerstation | October 28, 2026 |
The lineup reveals intelligent co-headlining strategy: Whitechapel, one of deathcore’s most established acts with roots nearly as deep as Lorna Shore’s own, appears exclusively on Australian dates. The Acacia Strain—a Massachusetts metalcore institution with a massive global fanbase—provides cross-genre appeal, while Organectomy, an emerging deathcore force, offers fresh energy throughout.
“We are beyond thrilled to announce we are returning for our biggest Australian headline shows to date AND we will be hitting New Zealand this time around.”
— Lorna Shore, via official announcement, May 27, 2026
What This Tour Means for Pacific Region Metal
The announcement signals a broader trend: major deathcore and metalcore acts are now treating Australia and New Zealand as major market destinations rather than secondary stops. Lorna Shore’s investment in arena-sized venues and multiple New Zealand performances reflects growing recognition of Pacific metals fans’ purchasing power and dedication. This directly contrasts with touring patterns from just three years ago, when many American metal bands relegated Australia to festival appearances only.
The tour also arrives amid Live Nation’s partnership with Spotify on exclusive ticket features launching this summer, which could benefit superfans seeking priority access to shows like these. Early ticket sales data from the initial announcement has been historically strong, with multiple sources reporting presale demand typical of headline-level productions.
Building on 2026’s Explosive Global Schedule
Lorna Shore launched 2026 with an extensive North American headlining tour featuring Paleface Swiss and Signs of the Swarm, running from April 17 through May 22 across the continent. Multiple festival appearances at Sonic Temple and Welcome to Rockville (both May 2026) preceded this announcement, establishing the band’s position as a touring juggernaut capable of managing both headline shows and festival slots simultaneously. The October Pacific dates represent the logical conclusion of an unprecedented touring year.
For North American fans comparing this to their spring tour experience, the Pacific leg shows similar production values and support lineups, suggesting Lorna Shore views this entire year as a pivotal moment for global expansion and market consolidation.
Will This Tour’s Success Lead to Extended Stays in 2027?
One critical question remaining: given the initial success of these October shows, will Lorna Shore return to Australia and New Zealand in 2027 for an extended run, or will 2026 remain their single domestic touring window? The band’s proven ability to command arena venues in the Pacific region could justify future multi-city tours or festival circuit involvement. Additionally, will support acts like Whitechapel receive equal billing on potential future returns, or does this tour represent their final co-headlining arrangement with Lorna Shore?
Sources
- Spotlight Report – Initial tour announcement and date confirmation
- Noise11.com – Complete venue and ticketing details
- Everyday Metal – Australian-specific tour analysis and presale information
- Blunt Magazine – Tour significance and industry context
- Ticketmaster NZ – Official New Zealand venue and date listings
- Lorna Shore Official Band Channels – Direct tour announcement and statement
